139 related articles for article (PubMed ID: 15259909)
21. Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation.
Huppmann AR; Roullet MR; Raffeld M; Jaffe ES
J Clin Oncol; 2013 Jan; 31(2):e28-30. PubMed ID: 23213091
[No Abstract] [Full Text] [Related]
22. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir.
Walling DM; Flaitz CM; Nichols CM
J Infect Dis; 2003 Sep; 188(6):883-90. PubMed ID: 12964120
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of darinaparsin for EBV-associated B-cell lymphoma in a heavily treated elderly patient with angioimmunoblastic T-cell lymphoma: a case report.
Ikeda D; Oura M; Uehara A; Tabata R; Narita K; Takeuchi M; Matsue K
Leuk Lymphoma; 2024 Jan; 65(1):132-135. PubMed ID: 37794793
[No Abstract] [Full Text] [Related]
24. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
Weiss LM; Jaffe ES; Liu XF; Chen YY; Shibata D; Medeiros LJ
Blood; 1992 Apr; 79(7):1789-95. PubMed ID: 1373088
[TBL] [Abstract][Full Text] [Related]
25. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.
Attygalle AD; Kyriakou C; Dupuis J; Grogg KL; Diss TC; Wotherspoon AC; Chuang SS; Cabeçadas J; Isaacson PG; Du MQ; Gaulard P; Dogan A
Am J Surg Pathol; 2007 Jul; 31(7):1077-88. PubMed ID: 17592275
[TBL] [Abstract][Full Text] [Related]
26. Three different expression patterns of T-bet in angioimmunoblastic T-cell lymphoma.
Jöhrens K; Dietel M; Anagnostopoulos I
Leuk Lymphoma; 2012 Jan; 53(1):152-5. PubMed ID: 21780995
[TBL] [Abstract][Full Text] [Related]
27. Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
Huang J; Zhang PH; Gao YH; Qiu LG
Diagn Cytopathol; 2012 Apr; 40(4):346-51. PubMed ID: 21472868
[TBL] [Abstract][Full Text] [Related]
28. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2007; 21(5):707-13. PubMed ID: 18019402
[TBL] [Abstract][Full Text] [Related]
29. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
[TBL] [Abstract][Full Text] [Related]
30. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis.
Vezina HE; Balfour HH; Weller DR; Anderson BJ; Brundage RC
J Clin Pharmacol; 2010 Jul; 50(7):734-42. PubMed ID: 19897764
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
32. Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.
Hoshino Y; Katano H; Zou P; Hohman P; Marques A; Tyring SK; Follmann D; Cohen JI
J Virol; 2009 Nov; 83(22):11857-61. PubMed ID: 19740997
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus genome level, T-cell clonality and the prognosis of angioimmunoblastic T-cell lymphoma.
Kawano R; Ohshima K; Wakamatsu S; Suzumiya J; Kikuchi M; Tamura K
Haematologica; 2005 Sep; 90(9):1192-6. PubMed ID: 16154842
[TBL] [Abstract][Full Text] [Related]
34. Secondary Cutaneous Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma with Hodgkin/Reed-Sternberg-like Cells in a Patient with Angioimmunoblastic T-cell Lymphoma.
Chen H; Xue YN; Xin CM; Xiong JS; Ni X; Sun JF
Acta Derm Venereol; 2018 Nov; 98(10):981-982. PubMed ID: 29956714
[No Abstract] [Full Text] [Related]
35. CD20-Positive nodal natural killer/T-cell lymphoma with cutaneous involvement.
Tsai YC; Chen CK; Wu YH
J Cutan Pathol; 2015 Sep; 42(9):639-44. PubMed ID: 25924981
[TBL] [Abstract][Full Text] [Related]
36. Occurrence of angioimmunoblastic T cell lymphoma in a patient with chronic myelomonocytic leukemia features.
Gaulier A; Jary-Bourguignat L; Serna R; Pulik M; Davi F; Raphaël M
Leuk Lymphoma; 2000 Dec; 40(1-2):197-204. PubMed ID: 11426621
[TBL] [Abstract][Full Text] [Related]
37. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature.
Xu Y; McKenna RW; Hoang MP; Collins RH; Kroft SH
Am J Clin Pathol; 2002 Dec; 118(6):848-54. PubMed ID: 12472277
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma.
Lee Y; Lee KW; Kim JH; Bang SM; Lee JS; Park BB; Kim WS; Suh C; Kang JH; Ryoo BY; Lee JH; Shin DB
Korean J Intern Med; 2008 Mar; 23(1):30-6. PubMed ID: 18363277
[TBL] [Abstract][Full Text] [Related]
39. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM
Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
[TBL] [Abstract][Full Text] [Related]
40. [Expression and Clinical Pathological Significance of EBER, PTEN and VEGF in Angioimmunoblastic T-Cell Lymphoma].
Wang F; Zhang GH; Ding KY; Liu L; Weng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):663-8. PubMed ID: 26117013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
